DCM
ASPX

DAFNA Capital Management’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

DAFNA Capital Management’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-120,500
Closed -$12.1M – 91
2015
Q1 		$12.1M Sell
120,500
-15,385
-11% -$1.02M 9.28% 3
2014
Q4 		$7.13M Sell
135,885
-16,117
-11% -$473K 5.64% 3
2014
Q3 		$3.9M Buy
+152,002
New +$3.23M 3.94% 6

DAFNA Capital Management's ASPX Position: Q2 2015 in Review

DAFNA Capital Management sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 120,500 shares — an estimated $12.1M sold.

DAFNA Capital Management first reported a position in ASPX in Q3 2014 and held it in 3 quarters. The position peaked at $12.1M in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • DAFNA Capital Management reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • DAFNA Capital Management sold 120,500 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $12.1M.
  • DAFNA Capital Management first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q3 2014 and held it in 3 quarters.
  • DAFNA Capital Management's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $12.1M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on DAFNA Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.